Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2885-2890

  Huuhtanen, Riikka Leena ^a   Blomqvist, Carl Peter ^a   Böhling, Tom Ove ^b   Wiklund, Tom Anders ^a   Tukiainen, Erkki Juhani ^a   Virolainen, Martti ^b   Tribukait, Bernhard ^c   Andersson, Leif Christer ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; DNA REPLICATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; CYCLIN A; FEMALE; FOLLOW-UP STUDIES; G2 PHASE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; S PHASE; SARCOMA; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033564486     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. El-Jahbour, J., Akhtar, S. S., Kerr, G. R., McLaren, K. M., Smyth, J. F., Rodger, A., and Leonard, R. C. Prognostic factors for survival in soft Tissue sarcoma. Br. J. Cancer, 62: 857-861, 1990.
2. van Diest, P., Baak, J. P., Matze, C. P., Wisse Brekelmans, E., van Galen, C., Kurver, P. H., Bellot, S. M., Fijnheer, J., van Gorp, L., Kwee, W. S., Los, J., Peterse, J., Ruilenberg, H., Schapers, R., Schipper, M., Somsen, J., Willig, A., and Ariens, A. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum. Pathol., 23: 603-607, 1992.
3. Huuhtanen, R. L., Blomqvist, C. P., Wiklund, T. A., Böhling, T. O., Virolainen, M. J., Tukiainen, E. J., Tribukait, B., and Andersson, L. A. A comparison of Ki-67 and S-phase fraction as prognostic variables in soft tissue sarcoma. Br. J. Cancer, 79: 945-951, 1998.
4. Huuhtanen, R. L., Blomqvist, C. P., Wiklund, T. A., Virolainen, M. J., Elomaa, A. I., Pan, Y., and Tribukait, B. S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome. Cancer (Phila.), 77: 1815-1822, 1996.
5. Jensen, V., Hoyer, M., Sorensen, F. B., Keller, J., and Jensen, O. M. MIB-1 expression and iododeoxyuridine labelling in soft tissue sarcomas: an immunohistochemical study including correlations with p53, bcl-2 and histological characteristics. Histopathology, 28: 437-444, 1996.
6. Joensuu, H., Toikkanen, S., and Klemi, P. J. DNA index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma. Cancer (Phila.), 66: 331-340, 1990.
7. 1 node negative breast cancer. Acta Oncol., 36: 369-374, 1997.
8. Sigurdsson, H., Baldetorp, B., Borg, A., Dalberg, M., Fernö, M., Killander, D., Olsson, H., and Ranstam, J. Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. Br. J. Cancer, 62: 786-790, 1990.
9. Bodey, B., Williams, R. T., Carbonaro, H. D., Horvath, A., Tolo, V. T., Luck, J. J., Taylor, C. R., and Hall, F. L. Immunocytochemical detection of cyclin A and cyclin D in formalin-fixed, paraffin-em bedded tissues: novel, pertinent markers of cell proliferation. Mod. Pathol., 7: 846-852, 1994.
10. Dirks, P. B., and Rutka, J. T. Current concepts in neuro-oncology: the cell cycle - a review. Neurosurgery (Baltimore), 40: 1000-1013, 1997.
11. Landberg, G., and Roos, G. The cell cycle in breast cancer. Apmis, 105: 575-589, 1997.
12. Grana, X., and Reddy, E. P. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11: 211-219, 1995.
13. Pines, J. Cyclins. CDKs and cancer. Semin. Cancer Biol., 6: 63-72, 1995.
14. Parwaresch, R., and Rudolph, P. The cell cycle: theory and application to cancer. Onkologie, 19: 464-472, 1996.
15. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G. Cyclin A is required at two points in the human cell cycle. EMBO J., 11: 961-971, 1992.
16. Girard, F., Strausfeld, U., Fernandez, A., and Lamb, N. J. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell, 67: 1169-1179, 1991.
17. Borg, Å., Sigurdsson, H., Clark, G. M., Fernö, M., Fuqua, S. A., Olsson, H., Killander, D., and McGurie, W. L. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer, 63: 136-142, 1991.
18. Schuuring, E., Verhoeven, E., van Tinteren, H., Peterse, J. L., Nunnink, B., Thunnissen, F. B., Devilee, P., Cornelisse, C. J., van de Vijver, M. J., Mooi, W. J., and Michalides, R. J. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52: 5229-5234, 1992.
19. Masuda, M., Hirakawa, N., Nakashima, T., Kuratomi, Y., and Komiyama, S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer (Phila.), 78: 390-395, 1996.
20. McIntosh, G. G., Anderson, I. J., Milton, I., Steward, M., Parr, A. H., Thomas, M. D., Henry, J. A., Angus, B., Lennard, T. W., and Horne, C. H. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene, 11: 885-891, 1995.
21. Michalides, R., van Veelen, N., Hart, A., Loftus, B., Wientjens, E., and Balm, A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res., 55: 975-978, 1995.
22. Shin, K. Y., Kong, G., Kim, W. S., Lee, T. Y., Woo, Y. N., and Lee, J. D. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. Br. J. Cancer, 75: 1788-1792, 1997.
23. Åkervall, J. A., Michalides, R. J., Mineta, H., Balm, A., Borg, A., Dictor, M. R., Jin, Y., Loftus, B., Mertens, F., and Wennerberg, J. P. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer (Phila.), 79: 380-389, 1997.
24. Kwa, H. B., Michalides, R. J., Dijkman, J. H., and Mooi, W. J. The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer. Lung Cancer, 14: 207-217, 1996.
25. Michalides, R., Hageman, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., and Peterse, J. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br. J. Cancer, 73: 728-734, 1996.
26. Fredersdorf, S., Burns, J., Milne, A. M., Packham, G., Fallis, L., Gillett, C. E., Royds, J. A., Peston, D., Hall, P. A., Hanby, A. M., Barnes, D. M., Shousha, S., O'Hare, M. J., and Lu, X. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. USA, 94: 6380-6385, 1997.
27. Gillett, C., Smith, P., Gregory, W., Richards, M., Millis, R., Peters, G., and Barnes, D. Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer, 69: 92-99, 1996.
28. Nielsen, N. H., Arnerlov, C., Emdin, S. O., and Landberg, G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br. J. Cancer, 74: 874-880, 1996.
29. Volm, M., Koomagi, R., Mattern, J., and Stammler, G. Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br. J. Cancer, 75: 1774-1778, 1997.
30. Volm, M., Rittgen, W., and Drings, P. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br. J. Cancer, 77: 663-669, 1998.
31. Wiklund, T., Huuhtanen, R., Blomqvist, C., Tukiainen, E., Virolainen, M., Virkkunen, P., Asko-Seljavaara, S., Björkenheim, J. M., and Elomaa, I. The importance of a multidisciplinary group in the treatment of soft tissue sarcomas. Eur. J. Cancer, 32A: 269-273, 1996.
32. Fletcher, J. Cytogenetic analysis of soft tissue tumors. In: F. Enzinger and S. Weiss (eds.), Soft Tissue Tumors, Third ed., pp. 105-118. St. Louis, MO: Mosby-Year Book, Inc., 1995.
33. Sheer, D. Chromosomes in solid tumors. In: L. M. Franks and N. M. Teich (eds.), Introduction to the Cellular and Molecular Biology of Cancer, Third ed., pp. 217-220. London: Oxford University Press, 1997.
34. Hedley, D. W. Flow cytometry using paraffin-embedded tissue: five years on. Cytometry, 10: 229-241, 1989.
35. Heiden, T., Wang, N., and Tribukait, B. An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry, 12: 614-621, 1991.
36. Enzinger, J., and Weiss, S. Soft Tissue Tumors, Third ed., pp. 6-12. St. Louis, MO: Mosby Year-Book, Inc., 1995.
37. Costa, J., Wesley, R. A., Glatstein, E., and Rosenberg, S. A. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer (Phila.), 53: 530-541, 1984.
38. Coindre, J. M., Trojani, M., Contesso, G., David, M., Rouesse, J., Bui, N. B., Bodaert, A., De, M. I., De, M. A., and Goussot, J. F. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer (Phila.), 58: 306-309, 1986.
39. Dutta, A., Chandra, R., Leiter, L. M., and Lester, S. Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc. Natl. Acad. Sci. USA, 92: 5386-5390, 1995.
40. Paterlini, P., Flejou, J. F., De Mitri, M. S., Pisi, E., Franco, D., and Brechot, C. Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters. J. Hepatol., 23: 47-52, 1995.
41. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
42. Darzynkiewicz, Z., Gong, J., Juan, G., Ardelt, B., and Traganos, F. Cytometry of cyclin proteins. Cytometry, 25: 1-13, 1996.
43. Elledge, S. J. Cell cycle checkpoints: preventing an identity crisis. Science (Washington DC), 274: 1664-1672, 1996.
44. Paulovich, A. G., Toczyski, D. P., and Hartwell, L. H. When checkpoints fail. Cell, 88: 315-321, 1997.
45. McLaughlin, C. L. Principles of Chemotherapy. In: R. B. Cameron (ed.), Practical Oncology, First ed., pp. 9-11. Los Angeles, CA: Prentice-Hall International Inc., 1994.
46. Zwijsen, R. M., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., and Michalides, R. J. CDK-independent activation of estrogen receptor by cyclin D1. Cell, 88: 405-415, 1997.
47. Pelosio, P., Barbareschi, M., Bonoldi, E., Marchetti, A., Verderio, P., Caffo, O., Bevilacqua, P., Boracchi, P., Buttitta, F., Barbazza, R., Dalla, P. P., and Gasparini, G. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Ann. Oncol., 7: 695-703, 1996.